Welcome : Guest

Immune Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Immune Pharmaceuticals, Inc., which is principally involved in Clinical-Stage Biopharmaceuticals Business. Illustrated with 64 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-64619
Price: $3200
Company Type: Public
Pages: 65
Date: November 2016
Market Data Tables: 64

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Anatomical Therapeutic Chemical (ATC-3) Indications......2
Table 1: Anatomical Therapeutic Chemical (ATC-3) Indications Market in Germany (2015) - Percentage Share Breakdown by Volume Sales for A02B Ulcer Treatments, B01C Anti-Platelet Treatments, C07A Beta-Blockers, Pure, M01A Anti-Phlog/Anti-Rheumatic, Non-Steroid, M02A Anti-Rheumatic and Analgesics, Topical, N02B Other Analgesics, R01A Nasal Preparations, Topical, R02A Throat Preparations, R05C Expectorants without Anti-Infectants, V03X Other Therapeutic Preparations, and Others......2
Antivirals......3
Table 2: Antiviral Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antiviral Drugs, Monoclonal Antibodies, Vaccines and Others......3
Rheumatoid Arthritis......4
Table 3: Rheumatoid Arthritis Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and Others......4
Table 4: Arthritis and Rheumatic Statistics in the US......5
Inflammatory Drugs......6
Table 5: Specialty Inflammatory Conditions Drugs Benefit Market by Category in the US (2015) - Percentage Share Breakdown by Value for Medical Benefit and Pharmacy Benefit......6
Topical Dermatology......7
Table 6: Anti-acne Topical Dermatology Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Acne, AK + Psoriasis + Dermatitis + Others, Anti-Fungal Combo, Anti-Infective, Coagulants, Corticosteroids Combo, and Corticosteroids Plain......7
Table 7: Extended Topicals & Specialty Generics Market by Product Category in the US (2015) -Percentage Share Breakdown by Value for Inhalers, Nasal, Ophthalmics, Oral Liquids, Patches, Topicals, and Others......8
Table 8: Dermatological Therapeutics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Acne, Anti-Infectives, Anti-Psoriasis, Corticosteroids, Topical and Other Dermatological Drugs, and Others......9
Acne Drugs......10
Table 9: Acne Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Isotretinoin, Topicals (Retinoid/Antibiotics), Oral Antibiotics, and Others......10
Table 10: Acne Drugs Market by Segments in the US (2015) - Percentage Share Breakdown by Volume for Orals and Topicals......11
Table 11: Topical Prescription Acne Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Cash Payment, Commercial, and Managed Medicaid Payment, Medicare Payment......12
Speciality Drugs......13
Table 12: Speciality Drug Sales by Therapeutic Category in the US (2015) - Percentage Market Share Breakdown by Value for Anticoagulants, Cancer, Growth Deficiency, Hepatitis C, HIV, Inflammatory Conditions, Multiple Sclerosis, Pulmonary Hypertension, Respiratory Conditions, Transplant and Others......13
Onychomycosis......14
Table 13: Onychomycosis Market by Treatment in the US (2015) - Percentage Share Breakdown by Value for Debridement, Oral Medication (Primarily Lamisil), Topical Treatments (Penlac and OTC Products*) and Untreated......14
Table 14: No. of Onychomycosis Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Debridement, Oral Medication (Primarily Lamisil), Topical Treatments (Penlac and OTC Products), and Untreated......15
Cancer Drugs......16
Table 15: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......16
Table 16: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......17
Cancer Market......18
Table 17: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......18
Table 18: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......19
Table 19: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......20
Table 20: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......21
Table 21: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......22
Table 22: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......23
Table 23: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......24
Table 24: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......25
Cancer Patients......26
Table 25: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......26
Table 26: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......27
Table 27: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......28
Table 28: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......29
Table 29: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......30
Table 30: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......31
Table 31: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......32
Table 32: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......33
Table 33: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......34
Table 34: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......35
Table 35: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......36
Table 36: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......37
Table 37: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......38
Table 38: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......39
Table 39: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......40
Table 40: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......41
Table 41: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......42
Table 42: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......43
Table 43: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......44
Table 44: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......45
Table 45: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......46
Cervical Cancer......47
Table 46: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......47
Table 47: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......48
Hematological Cancer......49
Table 48: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......49
Skin Cancer......50
Table 49: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......50
Cancer-Associated Mucositis......51
Table 50: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......51
Chronic Myelogenous Leukemia (CML)......52
Table 51: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......52
Multiple Myeloma......53
Table 52: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......53
Table 53: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......54
Anti-Inflammatory Biologics......55
Table 54: Market Shares of Leading Anti-Inflammatory Biologic Brands Worldwide (2015) - Percentage Share Breakdown by Value for Actemra, Enbrel, Humira, Remicade and Others......55
Monoclonal Antibodies......56
Table 55: Market Shares of Leading Monoclonal Antibody Production Companies in the US (2015) - Percentage Share Breakdown by Value for Abbvie Inc., AMGen, Johnson & Johnson, F. Hoffmann-La Roche AG and Others......56
Topical Acne Medication......57
Table 56: Market Shares of Leading Topical Acne Medication Manufacturers in the US (2015) - Percentage Share Breakdown by Volume for Allergan, Plc, Bayer AG, Galderma S.A., Valeant Pharmaceuticals International, Inc., and Others......57
Table 57: Market Shares of Leading Topical Acne Treatment Brands in the US (2015) - Percentage Market Share Breakdown by Volume for Acanya, Aczone, Differin, Epiduo, Finacea, and Others......58
Cancer Drugs......59
Table 58: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......59
Table 59: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2015) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......60
Table 60: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......61
Breast Cancer Drugs......62
Table 61: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......62
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......63
Table 62: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......63
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......64
Table 63: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......64
Table 64: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......65